BOULDER, CO / ACCESSWIRE / April 11, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid
Raising awareness around preventing lower limb diseases that can lead to pain, as well as expensive and lengthy treatment, is at the heart of a new paper from a team including experts from the University of Huddersfield.